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Abstract
Background—Recent evidence suggests that postpartum psychiatric episodes may share similar 
etiological mechanisms with immune-related disorders. Pre-eclampsia is one of the most prevalent 
immune-related disorders of pregnancy. Multiple clinical features are shared between pre-
eclampsia and postpartum psychiatric disorders, most prominently a strong link to first 
pregnancies. Therefore, we aimed to study if pre-eclampsia is a risk factor for first-onset 
postpartum psychiatric episodes.
Method—We conducted a cohort study using the Danish population registry, with a total of 400 
717 primiparous women with a singleton delivery between 1995 and 2011. First-lifetime 
childbirth was the main exposure variable and the outcome of interest was first-onset postpartum 
psychiatric episodes. The main outcome measures were monthly incidence rate ratios (IRRs), with 
the period 11–12 months after birth as the reference category. Adjustments were made for age, 
calendar period, reproductive history, and perinatal maternal health including somatic and 
obstetric co-morbidity.
Results—Primiparous women were at particularly high risk of first-onset psychiatric episodes 
during the first month postpartum [IRR 2.93, 95% confidence interval (CI) 2.53–3.40] and pre-
eclampsia added to that risk (IRR 4.21, 95% CI 2.89–6.13). Having both pre-eclampsia and a 
somatic co-morbidity resulted in the highest risk of psychiatric episodes during the 3-month period 
after childbirth (IRR 4.81, 95% CI 2.72–8.50).
Conclusions—We confirmed an association between pre-eclampsia and postpartum psychiatric 
episodes. The possible explanations for this association, which are not mutually exclusive, include 
the psychological impact of a serious medical condition such as pre-eclampsia and the 
neurobiological impact of pre-eclampsia-related vascular pathology and inflammation.
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Introduction
Childbirth has the highest relative risk of any vulnerability factor for the onset of serious 
psychiatric episodes such as depression, mania and psychosis (Jones et al. 2014). 
Furthermore, childbirth has also been associated with the substantial risk of additional 
psychiatric morbidity including personality, anxiety, adjustment and post-traumatic stress 
disorders (Howard et al. 2014). Several studies have demonstrated an increased risk during 
the first months after delivery for the onset of these episodes, compared with the risk of 
occurrence outside the postpartum period (Kendell et al. 1987; Munk-Olsen et al. 2006, 
2009). The acute onset of postpartum psychiatric episodes is a serious event for which both 
the mother and the child are at risk of infanticide and/or maternal suicide, as well as long-
term effects on social, emotional and cognitive outcomes (Grace et al. 2003; Stein et al. 
2014). Therefore, a deeper understanding of the underlying etiologies would greatly 
facilitate both the prevention and treatment of postpartum psychiatric episodes.
The pathogenesis of postpartum psychiatric disorders is considered complex and 
heterogeneous. Childbirth is a major life event with profound and often stressful changes in 
every aspect of daily life, which could make women vulnerable for psychiatric episodes. In 
addition, several neurobiological pathways are highly sensitized in the immediate 
postpartum period and could function as potential triggers (Bloch et al. 2003). Major 
alterations occur in steroid and stress hormones following delivery. However, evidence of a 
causual influence of steroid hormones on the onset of postpartum psychiatric episodes 
remains limited (Klier et al. 2007) and findings in the stress hormone axis in postpartum 
mood disorders have been inconclusive, as both increased and decreased activity have been 
reported (Harris et al. 1996; Parry et al. 2003; Groer & Morgan, 2007). Alternatively, the 
risk of postpartum psychiatric episodes might be more sensitive to the rapid change of 
hormone levels, rather than simply to the absolute levels of the hormones themselves (Bloch 
et al. 2003). In addition, it is likely that genetic factors influence the maternal response to 
these peripartum triggers. Accordingly, there is evidence for the familiarity of postpartum 
episodes but specific genes have not yet been identified (Jones et al. 2007; Byrne et al. 
2014).
Despite extensive efforts, a definitive pathophysiology for postpartum psychiatric disorders 
has remained elusive. Recently, based on a convergence of both immunological and 
epidemiological studies, there has been increasing support for the hypothesis that first-onset 
postpartum disorders may share similar etiological mechanisms with immune-related 
disorders (Gleicher, 2007; Bergink et al. 2013; Osborne & Monk, 2013). In our recent work, 
we showed that patients with severe first-onset postpartum episodes had abnormalities in 
monocyte activation and T cell function during the acute phase (Bergink et al. 2013) and a 
small subgroup of patients suffered from undiagnosed autoimmune encephalitis (Bergink et 
al. 2015a). In support of this hypothesis is the consistent finding that medical conditions 
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with a postpartum flare pattern – including postpartum thyroiditis, multiple sclerosis and 
rheumatoid arthritis – have an etiology originating from immune system dysfunction 
(Buyon, 1998; Confavreux et al. 1998; Gleicher, 2007; Haupl et al. 2008; Weetman, 2010).
Pre-eclampsia is a severe immune-related disorder of pregnancy. Interestingly, multiple 
clinical features are shared between pre-eclampsia and first-onset postpartum psychiatric 
disorders (Di Florio et al. 2014). The initial onset of both disorders is strongly associated 
with first pregnancy, compared with subsequent pregnancies. Furthermore, a history of a 
prior episode is the strongest known risk factor for each disorder in subsequent pregnancies 
(Steegers et al. 2010; Robillard et al. 2011; Munk-Olsen et al. 2014). Finally, several pre-
eclampsia studies have demonstrated increasing risk with longer intervals between 
subsequent pregnancies, a relationship that has recently been confirmed for first-onset 
postpartum psychiatric episodes (Munk-Olsen et al. 2014). Together, the shared pattern of 
risk between pre-eclampsia and postpartum psychiatric disorders may be evidence of a more 
fundamental relationship in their underlying pathophysiology (Steegers et al. 2010; 
Robillard et al. 2011; Di Florio et al. 2014; Munk-Olsen et al. 2014).
To date, the association between pre-eclampsia and severe postpartum psychiatric disorders 
has been examined only within disease-specific clinical cohorts (Brockington, 1996; 
Bergink et al. 2011). There is evidence linking pre-eclampsia and general psychiatric 
symptomatology such as anxiety and depressive symptoms (Delahaije et al. 2013), but 
conclusions were limited by difficulty in controlling for pre-pregnancy mental health. 
Therefore, the present study was designed to investigate the risk of a first-onset psychiatric 
episode after pre-eclampsia in primiparous women without psychiatric history. This large 
population-based Danish cohort study is the first epidemiological study in a general 
population on this topic.
Method
Study design and study population
We conducted an epidemiological population-based cohort study to investigate the 
association between pre-eclampsia (exposure) and the risk of a first-onset postpartum 
psychiatric episode (outcome). We identified all singleton births to primiparous women 
between 1 January 1995 and 31 December 2011. Each woman was followed within the 
cohort from the date of delivery until a postpartum psychiatric episode, migration, death or 
31 December 2012, whichever occurred first. As an additional restriction for uniformity, we 
considered only women born in Denmark from 1 January 1960 to 31 December 1995. In 
total, we identified 400 717 women who contributed 372 067 person-years, of which 2723 
mothers were recorded as having received either in-patient or out-patient treatment at a 
psychiatric facility within the initial 360 days postpartum.
Data resources and study variables
Information from three nationwide registers was linked for the present study. Registers were 
combined based on the unique Danish identification number assigned to each person at 
birth. We included information from the Civil Registration System on date of birth, parents’ 
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personal identification numbers, and daily updated information on vital status and migration 
(Pedersen, 2011).
Our main exposure variable was pre-eclampsia during primiparous pregnancies, identified 
using The Danish National Patient/Hospital Register (Andersen et al. 1999; Lynge et al. 
2011). This register contains information on all in-patient and out-patient treatment 
administered at medical hospitals in Denmark since 1995. Pre-eclampsia was defined by 
International Classification of Diseases, tenth version (ICD-10) code O14 (including 
moderate and severe pre-eclampsia). Importantly, pregnancy-induced hypertension (ICD-10 
code O13) and eclampsia (ICD-10 code O15) were not considered as exposure variables for 
the present study.
The outcome of interest was first-onset psychiatric episodes during the postpartum period. 
These data were derived from The Danish Psychiatric Central Research Register (Mors et al. 
2011), which holds information on all contacts with a psychiatric treatment facility in 
Denmark as in-patient and out-patient treatment during the entire study period. The 
diagnostic classification system used in Denmark is the ICD-10 (World Health 
Organization, 1994), from which we specifically used all diagnoses of mental and 
behavioral disorders in chapter V (F00–F99). A postpartum psychiatric episode was defined 
as any recorded contact with a psychiatric in-patient or out-patient treatment facility within 
the first 360 days postpartum, divided into monthly intervals (0–12 months). In addition, we 
conducted subanalyses for a more narrowly defined postpartum period within the first 90 
days following delivery (0–3 months) compared with 4–12 months postpartum, as the first 3 
months following childbirth have been associated with the highest lifetime risk of first-onset 
psychiatric episodes (Munk-Olsen et al. 2006). More detailed analyses were conducted on 
three diagnostic postpartum groups: unipolar depression (ICD-10 codes: F32, F33, F34, F38, 
F39), adjustment disorders (ICD-10 code: F43), and remaining diagnoses (remaining chapter 
V ICD-10 codes). Note that the subdivision into unipolar depression and adjustment 
disorders was made to provide additional clarification, since these episodes are the most 
frequently recorded diagnoses during the postpartum period. Further diagnostic subdivisions 
(e.g. bipolar disorder or a distinct diagnosis of postpartum psychosis (Bergink et al. 2015b) 
were not possible due to the reduction in statistical power that would result from the limited 
number of cases in many of the diagnostic subtypes. The analyses were restricted to include 
only first-onset episodes of mental disorders and not chronic disorders. Therefore, women 
with a registered diagnosis of any mental disorder occurring prior to the date of delivery 
were excluded from this study.
A range of potential confounders were considered as covariates: gestational diabetes 
(ICD-10 codes O24.4 and O24.9) and birth complications (an overall measure of number of 
recorded birth-related complications divided into three groups: 0–8 recorded complications, 
9–14 recorded complications and 15+ complications). We furthermore adjusted for 
reproductive histories, defined as records of induced abortions (ICD-10 codes O04, O05, 
O06), spontaneous abortions (ICD-10 codes O021, O03) and stillbirths (ICD-10 codes Z371, 
Z374, Z377, P95). Additionally, we adjusted the analyses for family history of psychiatric 
disorders (grandparents of index child having records of any treatment at a psychiatric 
facility) and somatic co-morbidities using the Charlson co-morbidity index (Charlson et al. 
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1987). The Charlson co-morbidity index is an indicator of medical disease burden and 
consists of 19 severe chronic diseases. Each disease is assigned a weight from one to six 
corresponding to the severity of the disease, and the score is subsequently calculated as the 
sum of all weights. All of the mentioned covariates were handled as time-dependent 
variables.
Statistical analysis
For the present study, analyses included calculation of incidence rates of psychiatric hospital 
contacts per 1000 person-years under risk. Furthermore, we conducted a survival analysis 
(Poisson regression) and calculated incidence rate ratios (IRRs). We calculated the IRRs of 
psychiatric contacts at monthly intervals for the first year postpartum, while the incidence 
rate 11–12 months after the birth was defined as the reference category. In the interaction 
analysis of pre-eclampsia with the Charlson co-morbidity index and gestational diabetes, we 
examined the risks of overall psychiatric episodes from 0–3 months (0–90 days) and 4–12 
months (91–360 days) postpartum, due to the limited number of cases. We adjusted the 
IRRs for age, calendar period, reproductive history, gestational diabetes, maternal well-
being around childbirth (number of diagnoses related to the specific childbirth), somatic co-
morbidity (Charlson co-morbidity index) and family history of psychiatric disorders.
Results
A total of 400 717 women were included in our cohort study, of whom 17 149 had a 
diagnosis of pre-eclampsia (4.28%). A total of 2723 women received psychiatric treatment 
for any type of psychiatric diagnosis within the first 360 days postpartum, including 435 
women via in-patient treatment and 2297 receiving treatment at out-patient mental health 
services. Out of the 2723 women with psychiatric episodes during the first 360 days 
postpartum, 162 had pre-eclampsia during pregnancy (5.93%). Among the 39.8% (n = 1087) 
of women who received their psychiatric diagnosis during the first 3 months postpartum, 71 
had pre-eclampsia during pregnancy (6.53%).
Incidence rates of psychiatric contacts during the postpartum period are shown in Fig. 1, 
with the highest incidence of first-onset psychiatric episodes within the first month 
postpartum observed in women with or without pre-eclampsia. The corresponding IRRs are 
shown in Fig. 2. The first month postpartum was associated with the highest risk of 
psychiatric episodes for mothers with pre-eclampsia [IRR 4.21, 95% confidence interval 
(CI) 2.89–6.13] and without pre-eclampsia (IRR 2.93, 95% CI 2.53–3.40), compared with 
the reference category of women who gave birth 11–12 months prior with no pre-eclampsia 
(Fig. 2). The overall effect of pre-eclampsia on the risk of psychiatric episodes from 0 to 12 
months after birth was IRR 1.43 (95% CI 1.22–1.68; results not shown).
For subanalyses, we defined three diagnostic groups [unipolar depression (ICD-10 codes: 
F32, F33, F34, F38, F39), adjustment disorder (F43) and other psychiatric diagnoses (any 
other chapter V code)] to identify possible changes in the risk of occurrence of an episode 
(Table 1). For all three groups, the highest risks were observed 0–3 months postpartum in 
women with pre-eclampsia [unipolar depression (IRR 2.85, 95% CI 1.84–4.42), adjustment 
disorder (IRR 4.04, 95% CI 2.85–5.72), other disorders (IRR 1.90, 95% CI 1.17–3.07)]. As 
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CIs were overlapping for the above-mentioned results, there was no statistical difference in 
risk of the studied diagnostic subgroups. For this reason the results presented below focus on 
the single overall diagnostic group containing all psychiatric disorders as the outcome 
variable.
Stratified analyses were performed for somatic co-morbidity and gestational diabetes to 
investigate potentially moderating influences in the relationship between postpartum 
psychiatric episodes and pre-eclampsia. Having both pre-eclampsia and a somatic co-
morbidity defined by the Charlson co-morbidity index yielded the highest risk of first-onset 
psychiatric episodes during the interval of 0–3 months postpartum, compared with women 
without somatic co-morbidities in the reference category (IRR 4.81, 95% CI 2.72–8.50) 
(Table 2). In particular, women with both gestational diabetes and pre-eclampsia had a 
significantly elevated risk of psychiatric episodes 0–3 months postpartum compared with 
mothers without these two disorders (IRR 3.86, 95% CI 1.24–12.00) (Table 3).
Discussion
This population-based cohort study demonstrates that all primiparous women are at risk of 
first-onset psychiatric episodes during the early postpartum period, but that pre-eclampsia 
adds considerably to that risk. This is observed broadly across psychiatric diagnoses in 
general, as well as independent for each of the following diagnostic groups: unipolar 
depression, adjustment disorders, and other psychiatric disorders. Further, our study 
confirms the well-described association between somatic co-morbidities and psychiatric 
episodes, as an increasing burden of somatic diseases or pregnancy complications such as 
gestational diabetes significantly increases the risk for postpartum psychiatric episodes, 
especially in women with pre-eclampsia. Explanations for the association between pre-
eclampsia and first-onset psychiatric episodes could be sought in both psychological and 
neurobiological models, which are not mutually exclusive.
Effects of maternal and neonatal adverse events
Pre-eclampsia is associated with perinatal complications such as preterm delivery, poor 
neonatal outcome and death. It is plausible that these adverse events lead to feelings of stress 
and grief, making women vulnerable for psychiatric episodes after delivery. Indeed, 
unfavorable outcomes after pre-eclampsia have been described as a risk factor for 
postpartum depression (Hoedjes et al. 2011). In the present studies, cases of eclampsia or 
neonatal death were excluded and therefore by adjusting the results for gestational age and 
birth complications, we aimed to overcome this potential bias. Nevertheless, the 
psychological impact of a serious medical condition such as pre-eclampsia might have 
contributed to the vulnerability for psychiatric episodes postpartum.
Maternal–fetal incompatibility
There are three clinical characteristics of serious postpartum psychiatric episodes that show 
a remarkable overlap with pre-eclampsia: primiparity, a high recurrence risk after a 
subsequent pregnancy, and increased risk with prolonged birth interval. Accordingly, these 
associations raise the possibility of a shared biological mechanism. Pre-eclampsia is 
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considered to be a disease of immunological maternal–fetal incompatibility. An 
immunological maternal–fetal conflict is thought to result in pathophysiological changes in 
the placenta early in pregnancy, preceding the clinical symptoms of pre-eclampsia (Sargent 
et al. 2006; Steegers et al. 2010; Roberts & Bell, 2013). During a first pregnancy, paternally 
inherited antigens expressed by the fetus are viewed by the maternal immune system as 
foreign. In contrast, during subsequent pregnancies the maternal immune system has already 
had the opportunity to develop tolerance to paternally inherited antigens expressed by the 
fetus. This pathophysiological model elegantly accounts for the well-replicated findings of 
decreased risk of pre-eclampsia during subsequent pregnancies, compared with a woman’s 
first pregnancy in which the risk is highest (Sargent et al. 2006; Steegers et al. 2010). 
Consistent with this epidemiological finding, increasing intervals and/or a new partner have 
been shown to reduce maternal tolerance and thereby increase pre-eclampsia risk (Tandberg 
et al. 2015).
In theory, maternal–fetal incompatibility could potentially explain many of the similarly 
enigmatic clinical characteristics of acute postpartum episodes, including the substantially 
increased risk of first pregnancies and an increasing risk with longer intervals between 
subsequent pregnancies. However, one important difference between postpartum disorders 
and pre-eclampsia is the timing of onset of clinical symptoms. Pre-eclampsia is a disease of 
pregnancy, in which delivery resolves the pathophysiological process, whereas the highest 
known risk factor for the onset of psychiatric disorders falls within the early postpartum 
interval following delivery. Accordingly, maternal immune-related pathophysiological 
changes early in pregnancy could only lead to acute postpartum episodes several months 
later if there is a second trigger around the time of delivery.
Vascular damage
When considering pathophysiological changes later in pregnancy and closer to the 
postpartum onset of psychiatric episodes, the second pathophysiological stage of pre-
eclampsia might be of interest. This stage is characterized by excessive endothelial 
activation and a generalized hyperinflammatory state compared with normal pregnancy 
(Redman & Sargent, 2001; Sargent et al. 2006; Steegers et al. 2010). Widespread 
endothelial dysfunction establishes a high vulnerability to disruption of the blood–brain 
barrier (Amburgey et al. 2010). An increased permeability of the blood–brain barrier, in the 
setting of a hyperinflammatory state, is known to broadly influence brain function, including 
neurotransmitter metabolism, neuroendocrine function and synaptic plasticity (Capuron & 
Miller, 2011; Bergink et al. 2014). Together, vascular inflammation as observed in pre-
eclampsia could be seen as a candidate neurobiological vulnerability mechanism for 
psychiatric disorders. The systemic consequences of this vascular inflammation, such as 
renal and liver dysfunction (including insulin resistance), could further influence brain 
function. Under this model, psychiatric episodes could be seen as the direct consequence of 
the later-stage pathophysiological changes of pre-eclampsia.
Methodological considerations
The present study is based on data from Danish population registers covering the entire 
nation, thereby providing information on a large, unselected group of women during 
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pregnancy. However, there are certain limitations to the data, including the definition of our 
main outcome of interest: any type of psychiatric disorder treated at an in-patient or out-
patient psychiatric treatment facility. The present study included primiparous pregnancies 
and first-onset psychiatric episodes as exposure and outcome variables. It is likely that 
women in our cohort are less likely to continue reproducing (Laursen & Munk-Olsen, 2010), 
and hence generalizability to multiparous women can be questioned. As this information is 
obtained from women who actively sought care, the rates of psychiatric episodes presented 
in the present study may be an underestimation of the true population incidence. 
Furthermore, our results do not provide information on less severe mental health problems 
treated through primary care providers. In an effort to avoid bias by clinical heterogeneity, 
the present study focused exclusively on primiparous mothers with no previous evidence of 
psychiatric history. Importantly, we acknowledge that this decision also potentially limits 
the generalizability of our findings. Residual confounding factors cannot be excluded since 
unmeasured patient characteristics may have influenced our results, including the lack of 
information regarding diseases of milder severity not captured by the Charlson co-morbidity 
index, lifestyle factors such as obesity and smoking, as well as aspects regarding infant 
health.
Conclusion
This population-based cohort study demonstrates that primiparous women are at high risk of 
first-onset psychiatric episodes particularly during the early postpartum period. The present 
study confirms a link between pre-eclampsia and postpartum psychiatric episodes, mainly 
representing unipolar depression and adjustment disorders. Additionally, our findings 
suggest a particularly elevated risk of postpartum episodes in women with somatic and 
obstetric co-morbidities, compared with women without these co-morbidities. Explanatory 
models linking pre-eclampsia and postpartum episodes could include exogenous and/or 
endogenous factors:
(1) The psychological impact of a serious medical condition such as pre-eclampsia 
might have contributed to the vulnerability for psychiatric episodes.
(2) An underlying immune-mediated pathophysiological mechanism could lead to 
both pre-eclampsia and postpartum psychiatric episodes. In particular, vascular 
pathology and hyperinflammation are important candidate vulnerability triggers 
for postpartum psychiatric episodes.
The clinical relevance of our findings is most importantly found among pregnant 
primiparous patients with somatic co-morbidities including pre-eclampsia, in whom 
clinicians should be aware of the increased risk of first-onset postpartum psychiatric 
episodes.
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Incidence rates per 1000 person-years for psychiatric contacts in primiparous mothers with 
and without pre-eclampsia 0–12 months postpartum. Values are incidence rates, with 95% 
confidence intervals represented by vertical bars.
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Incidence rate ratios for psychiatric contacts in primiparous mothers with (--■--) and 
without (–●–) pre-eclampsia 0–12 months postpartum. Adjusted for age, calendar period, 
birth complications (number of diagnoses related to childbirth), reproductive history, 
gestational diabetes, somatic co-morbidities and family history of psychiatric disorders. 
Values are incidence rate ratios, with 95% confidence intervals represented by vertical bars.
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Table 1
Incidence rate ratios of first-onset depression, adjustment and remaining diagnoses 0–3 













Unipolar depression 2.85 (1.84–4.42) 1.25 (0.84–1.84) 2.11 (1.83–2.43) 1 (reference category)
  n 21 27 325 456
Adjustment disorder 4.04 (2.85–5.72) 1.54 (1.10–2.14) 2.29 (2.02–2.61) 1 (reference category)
  n 34 38 420 537
Other disorders 1.90 (1.17–3.07) 0.99 (0.67–1.47) 1.49 (1.29–1.72) 1 (reference category)
  n 17 26 289 570
Data are given as incidence rate ratio (95% confidence interval).
a
Adjusted for age, calendar period, birth complications (number of diagnoses related to childbirth), reproductive history, somatic co-morbidities 
(Charlson co-morbidity index) and family history of psychiatric disorders. If a woman had records of more than one of the diagnoses of interest 
(dual diagnoses), she contributed with information in more than one category.
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Table 2
Somatic co-morbidity, pre-eclampsia and incidence rate ratios of first-onset psychiatric 













Yes (1+ score) 4.81 (2.72–8.50) 1.22 (0.63–2.35) 2.18 (1.73–2.76) 1.43 (1.20–1.69)
  n 12 9 75 143
No (0 score) 2.78 (2.14–3.61) 1.32 (1.06–1.65) 1.97 (1.81–2.14) 1 (reference category)
  n 59 82 941 1402
Data are given as incidence rate ratio (95% confidence interval).
a
Adjusted for age, calendar period, birth complications (number of diagnoses related to childbirth), reproductive history, gestational diabetes and 
family history of psychiatric disorders.
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Table 3
Gestational diabetes, pre-eclampsia and incidence rate ratios of first-onset psychiatric 
episodes 0–3 and 4–12 months postpartum in primiparous mothers
a
Pre-eclampsia No pre-eclampsia
Gestational diabetes 0–3 months postpartum 4–12 months postpartum 0–3 months postpartum 4–12 months postpartum
Yes 3.86 (1.24–12.00) 1.32 (0.43–4.12) 2.35 (1.49–3.70) 1.60 (1.15–2.23)
  n 3 3 19 37
No 2.89 (2.27–3.69) 1.28 (1.03–1.59) 1.94 (1.79–2.10) 1 (reference category)
  n 68 88 997 1508
Data are given as incidence rate ratio (95% confidence interval).
a
Adjusted for age, calendar period, birth complications (number of diagnoses related to childbirth), reproductive history, somatic co-morbidities 
(Charlson co-morbidity index) and family history of psychiatric disorders.
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